Loading the company…
Loading the company…
㈜디벨로바이오
English name as filed with DART, Korea’s corporate disclosure system · Correct the English name ›
Last updated 2026-11-02 · Korean page ›
Verification level — how far we have checked
L0 · Public records — NPS workforce · filed financials · patents — public data
A company based in Gyeonggi, founded in 2006. Industry: Wholesale & Retail. Revenue for 2025 was ₩18.7bn. It has 16 employees enrolled in the National Pension Service (as of Aug 2026). It is externally audited; the latest audit opinion is “Unqualified”.
Loading…
Latest filing 2016-10-17 · latest registration 2017-12-07 · newest first
본 고안은 무 바늘 주사기에 관한 것이다. 본 고안은, 내부에 약 액이 담기고 한쪽 끝에 약 액이 배출되는 배출구가 형성된 팁을 갖춘 주사기 본체; 상기 본체의 내부에 장착되며 상기 약 액을 흡입 및 토출시키기 위한 피스톤; 및 상기 팁에 장착되며 상기 약 액이 유출되는 것을 방지하는 보호 캡을 포함하는 무 바늘 주사기에 있어서, 상기 팁은 배출구 측에서 본체로 갈수록 경사진 원뿔 형상으로 형성된 것을 포함하며; 상기 팁의 외주 면에는 팁이 삽입되는 피삽입부와의 접촉 면적을 줄이기 위해 길이 방향으로 복수 개의 그루브가 형성된 것을 더 포함하고; 상기 보호 캡은 상기 팁의 외형과 상응하며 입구는 폭이 넓고 바닥 부는 폭이 좁게 형성되되 내주 면에는 상기 그루브와 대응하는 복수 개의 돌기가 구비되되 바닥 면에는 상기 배출구를 밀폐하는 단면 반구 형상의 속 마개가 구비된 것을 특징으로 한다.
KIPO KIPRIS · checked 2026-10-15 · newest filings first · right: registration date (filing date if not yet registered) · 1 of 1 · titles and abstracts are in Korean as filed · click a row for details ▾
For now we hold public records only (National Pension Service · DART filings · patents · registers · press). When the company files material in our IR Room, it moves to L1. We do not score or rate companies — we only state how far we have checked.
| KRW bn | 2024 | 2025 |
|---|---|---|
| Revenue | 16.8 | 18.7 |
| Cost of sales | 13.4 | 15.8 |
| Gross profit (loss) | 3.4 | 2.9 |
| Selling, general and administrative expenses | 2.8 | 2.2 |
| Operating income (loss) | 0.5 | 0.7 |
| Non-operating income | 0.1 | 0.1 |
| Other gains | 0.0 | 0.0 |
| Finance income | 0.0 | 0.0 |
| Other | 0.0 | 0.1 |
| Non-operating expenses | 0.4 | 0.4 |
| Other losses | 0.0 | 0.0 |
| Finance costs | 0.4 | 0.4 |
| Other | — | 0.0 |
| Profit (loss) before tax | 0.2 | 0.4 |
| Income tax expense | 0.0 | — |
| Net income (loss) | 0.2 | 0.4 |
Revenue ₩18.7bn, up 11.5% YoY.
Operating margin 3.7% (prior 3.2%).
Net income ₩0.4bn.
Need more than is shown here? Ask for more information — full review report · valuation · executive teaser · IM · competitor analysis · due diligence. Tell us what you need and we will reply by email with scope, cost and timing.
Is this your company?
If anything here is wrong, tell us — we check it against the original and correct it. You do not need to join. If you would like your financials verified and this page completed, that is a separate process.
Headlines and links to public articles only · not checked by us (original ↗) · articles are in Korean — English headlines are our translation; where none is shown, “Read in English ›” opens a machine translation · “Broker view” is a forecast, not reported results · checked 2026-11-06